Lycopene ameliorates skin aging by regulating the insulin resistance pathway and activating SIRT1

Jing Li1,2, Xin Zeng3,2, Xiaolong Yang1

  • 1School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, P. R. China. yxl19830915@163.com.

Food & Function
|October 13, 2022
PubMed

Insights

Lycopene (Ly) reverses skin aging by improving microvascular health and combating insulin resistance. This antioxidant promotes cell repair and blood vessel regeneration, protecting aging skin.

Area of Science:

  • Dermatology
  • Gerontology
  • Biochemistry

Background:

  • Skin aging is characterized by microvascular loss, impacting skin health.
  • Microvascular dysfunction and insulin resistance are key features of aged skin.

Purpose of the Study:

  • To investigate the effects of lycopene on skin aging, focusing on microvascular renewal and insulin resistance.
  • To elucidate the underlying mechanisms of lycopene's protective effects on aging skin cells and tissues.

Main Methods:

  • In vitro studies using aged primary skin fibroblast cells (PRSFs) treated with lycopene.
  • In vivo studies involving aged rats subjected to lycopene intervention.
  • Analysis included reactive oxygen species (ROS), ATP, NAD+/NADH, mitochondrial membrane potential (MMP), Fibrillin-I, VEGF, insulin pathway proteins, and SIRT1 expression.
  • Metabolomic analysis (LC-MS) and KEGG pathway analysis were employed.

Main Results:

  • Lycopene reduced oxidative stress (ROS), senescence markers (β-galactosidase, AGEs), and improved mitochondrial function (ATP, NAD+/NADH, MMP) in vitro.
  • Lycopene increased Fibrillin-I and VEGF expression in aged skin cells.
  • In vivo, lycopene reversed reduced capillary density, blood flow, and signs of skin aging and mitochondrial disorder in aged rats.
  • Lycopene intervention improved insulin sensitivity and upregulated VEGF and SIRT1 expression.

Conclusions:

  • Lycopene effectively protects aging skin by promoting microvascular neovascularization.
  • Lycopene may reverse insulin resistance via the SIRT1 pathway during skin aging.
  • The findings highlight lycopene's potential as a therapeutic agent for age-related skin conditions.

Related Concept Videos

Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.4K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K